Combined neoadjuvant weekly paclitaxel and trastuzumab for HER2-overexpressing breast cancer

被引：0
|
作者：
Horiguchi, J. [1 ]
Koibuchi, Y. [1 ]
Rokutanda, N. [1 ]
Nagaoka, R. [1 ]
Kikuchi, M. [1 ]
Sato, A. [1 ]
Ishikawa, Y. [1 ]
Odawara, H. [1 ]
Iino, Y. [1 ]
Takeyoshi, I. [1 ]
机构：
[1] Gunma Univ Hosp, Maebashi, Gunma, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3045
引用
收藏
页数：1
相关论文
共 50 条
  • [21] TBCRC 006: A multicenter phase II study of neoadjuvant lapatinib and trastuzumab in patients with HER2-overexpressing breast cancer
    Chang, J. C. N.
    Mayer, I. A.
    Forero-Torres, A.
    Nanda, R.
    Goetz, M. P.
    Rodriguez, A. A.
    Pavlick, A. C.
    Wang, T.
    Hilsenbeck, S. G.
    Gutierrez, C.
    Schiff, R.
    Osborne, C. K.
    Rimawi, M. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [22] Paclitaxel-Trastuzumab Mixed Nanovehicle to Target HER2-Overexpressing Tumors
    Nieto, Celia
    Centa, Ariana
    Rodriguez-Rodriguez, Jesus A.
    Pandiella, Atanasio
    Martin del Valle, Eva M.
    NANOMATERIALS, 2019, 9 (07):
  • [23] Weekly Paclitaxel and Trastuzumab as a First-Line Therapy in Patients with HER2-Overexpressing Metastatic Breast Cancer: Magnitude of HER2/neu Amplification as a Predictive Factor for Efficacy
    Han, Hye-Suk
    Kim, Jin-Soo
    Park, Jin Hyun
    Jeon, Yoon Kyung
    Lee, Keun-Wook
    Oh, Do-Youn
    Kim, Jee Hyun
    Park, So Yeon
    Im, Seock-Ah
    Kim, Tae-You
    Park, In Ae
    Bang, Yung-Jue
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2009, 24 (05) : 910 - 917
  • [24] Treatment of HER2-overexpressing breast cancer
    Baselga, J.
    ANNALS OF ONCOLOGY, 2010, 21 : 36 - 40
  • [25] Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer
    Valabrega, G.
    Montemurro, F.
    Aglietta, M.
    ANNALS OF ONCOLOGY, 2007, 18 (06) : 977 - 984
  • [26] Tolerability and activity of trastuzumab in elderly patients with HER2-overexpressing metastatic breast cancer
    Zucchini, G.
    Bernardi, A.
    Martoni, A.
    Zamagni, C.
    ANNALS OF ONCOLOGY, 2013, 24 (01) : 264 - 265
  • [27] Trastuzumab-targeted gene delivery to Her2-overexpressing breast cancer cells
    K Mann
    M Kullberg
    Cancer Gene Therapy, 2016, 23 : 221 - 228
  • [28] Trastuzumab induces gastrointestinal side effects in HER2-overexpressing breast cancer patients
    Noor Al-Dasooqi
    Joanne M. Bowen
    Rachel J. Gibson
    Thomas Sullivan
    Jude Lees
    Dorothy M. Keefe
    Investigational New Drugs, 2009, 27 : 173 - 178
  • [29] Trastuzumab induces gastrointestinal side effects in HER2-overexpressing breast cancer patients
    Al-Dasooqi, Noor
    Bowen, Joanne M.
    Gibson, Rachel J.
    Sullivan, Thomas
    Lees, Jude
    Keefe, Dorothy M.
    INVESTIGATIONAL NEW DRUGS, 2009, 27 (02) : 173 - 178
  • [30] Met receptor contributes to trastuzumab resistance of Her2-overexpressing breast cancer cells
    Shattuck, David L.
    Miller, Jamie K.
    Carraway, Kermit L., III
    Sweeney, Colleen
    CANCER RESEARCH, 2008, 68 (05) : 1471 - 1477
12345